The impact of the sleep apnea syndrome on oxidant-antioxidant balance in the blood of overweight and obese patients

Journal of Physiology and Pharmacology

Volumn 59, Issue SUPPL. 6, 2008, Pages 761-769

  Wysocka, E ^a,c   Cofta, S ^b   Cymerys, M ^c   Gozdzik, J ^b   Torlinski, L ^a   Batura Gabryel, H ^b  

^a Department of Clinical Biochemistry and Laboratory Medicine   (Poland)

^b Department of Pulmonary Diseases ^*  (Poland)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Body mass index; Obstructive sleep apnea syndrome; Oxidative stress markers

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; CHOLESTEROL; COPPER ZINC SUPEROXIDE DISMUTASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZING AGENT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; SUPEROXIDE DISMUTASE;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROL GROUP; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ERYTHROCYTE; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; OBESITY; OXIDATIVE STRESS; SLEEP APNEA SYNDROME; SYSTOLIC BLOOD PRESSURE; BLOOD; ENZYMOLOGY; EXTRACELLULAR SPACE; METABOLISM; MIDDLE AGED; POLYSOMNOGRAPHY;

ADULT; AGED; ANTIOXIDANTS; BODY MASS INDEX; ERYTHROCYTES; EXTRACELLULAR SPACE; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; OXIDANTS; POLYSOMNOGRAPHY; SLEEP APNEA SYNDROMES; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 64549109302     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Stern M, Williams K, Gonzales-Villalpando C et al. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 2004; 27: 2676-2681.
2. Kiely J, McNicholas W. Cardiovascular risk factors in patients with obstructive sleep apnea syndrome. Eur Respir J 2000; 16: 128-133.
3. McNicholas WT. Sleep apnea syndrome. Breathe 2005; 1: 219-227.
4. Peppard R, Young T, Palta M, Skatrud J. Prospective study of the association between sleep disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-1384.
5. Lavie L. Obstructive sleep apnoea syndrome - an oxidative stress disorder. Sleep Med Rev 2003; 7: 35-51.
6. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82:47-95.
7. Bast A, Haenen GRMM, Doelman CJA. Oxidants and Antioxidants: State of the Art. Am J Med 1991; 91 Suppl 3C: 2S-13S.
8. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004; 24: 816-23.
9. Halliwell B. Reactive oxygen species in living systems: Source, biochemistry, and role in human disease. Am J Med 1991; 91 Suppl 3C: 14S-22S.
10. Milner NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status of premature neonates. Clin Sci 1993; 84: 407-412.
11. Raport of a WHO Study Group. Prevention of diabetes mellitus. World Health Organization. Geneva 1994. WHO Tech. Rep. Ser. No 844.
12. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976; 15:212-216.
13. Banerjee D, Brendon J, Yee J et al. Obesity Hypoventilation Syndrome. Chest 2007; 131: 1678-1684.
14. Alam I, Lewis K, Stephens JW, Baxter JN. Obesity, metabolic syndrome and sleep apnoea: all proinflammatory states. Obes Rev 2006; 8: 119-127.
15. Knutson K, Spiegel K, Penev P et al. The metabolic consequences of sleep deprivation. Sleep Med Rev 2007; 11: 163-178.
16. Schulz R, Mahmoudi S, Hattar K et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Am J Respir Crit Care Med 2000; 162: 566-570.
17. Chorostowska-Wynimko J, Radomska D, Plywaczewski R et al. Disturbed angiogenic activity in sera from obstructive sleep apnea patients. J Physiol Pharmacol 2005; 56 Suppl 4: 71-77.
18. Lam J, Ip M. An Update on Obstructive Sleep Apnea and the Metabolic Syndrome. Curr Opin Pulm Med 2007; 13: 484-489.
19. Kono M, Tatsumi K, Saibara T et al. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 2007; 131: 1387-1392.
20. Namyslowski G, Scierski W, Mrowka-Kata K, Kawecka I, Kawecki D, Czecior E. Sleep study in patients with overweight and obesity. J Physiol Pharmacol 2005; 56 Suppl 6: 59-65.
21. Barcelo A, Barbe F, de la Pena M et al. Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 2006; 27: 756-760.
22. Lavie L, Vishnevsky A, Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep2004; 27: 123-128.
23. Alzoghaibi MA, Bahammam AS. Lipid peroxides, superoxide dysmutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea: a pilot study. Sleep Breath 2005; 9: 119-26.
24. Minoguchi K, Yokoe T, Tanaka A et al. Association between lipid peroxidation and inflammation in obstructive sleep apnoea. Eur Resp J 2006; 28: 378-385.
25. Beltowski J, Wojcicka G, Gorny D, Marciniak A. The effect of dietary-induced obesity on lipid peroxidation, antioxidant enzymes and total plasma antioxidant capacity. J Physiol Pharmacol 2000; 51: 883-896.